Price $26.87 |
Market Cap
264M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
29.8
|
P/B
1.76
|
P/S
0.72
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-49.2K
|
FCF
-4.5
|
|
Op. Margin
3.40%
|
Net Margin
2.50%
|
ROE
6.30%
|
ROI
8.40%
|
|
ROA
4.20%
|
EPS Growth
-29.70%
|
Current Ratio
2.4
|
Debt/Equity
1.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.96 | - | - | 82.6M | Strong Buy |
| Spine Injury Solutions Inc (SPIN) | $0.28 | - | - | 8M | Strong Buy |
| Genomic Health, Inc. (GHDX) | $29.22 | - | - | 883.7M | Strong Buy |
| Cogentix Medical Inc (CGNT) | $1.81 | - | - | 29M | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.79 | - | - | 24.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
